EUKON Legality Rating awarded
Caserta, ITALY – 03 Feb 2026 Legality Rating awarded 🚀…
Gender matter! EUKON move on mission 5
Caserta, ITALY – August 8th, 2023 We are absolutely…
SUPRAFLEX-TALENT trial 3yr follow-up has been presented at EuroPCR 2021
At EuroPCR 2021 TALENT 3yrs follow up has been presented. Supraflex stent showed to be as safe and effective as Xience family stent in all-comers population.
Latest News:
EUKON FT1000 ranking 2022 on Financial Times
FT 1000: the sixth annual list of Europe’s fastest-growing companies…